• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG PET-CT 代谢指标对鼻咽癌的预后价值。

Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.

机构信息

Department of Radiation Oncology, Shandong Tumor Hospital and Institute, Jiyan Road 440, 250117 Jinan, Shandong, China.

出版信息

J Cancer Res Clin Oncol. 2010 Jun;136(6):883-9. doi: 10.1007/s00432-009-0729-7. Epub 2009 Nov 20.

DOI:10.1007/s00432-009-0729-7
PMID:19936788
Abstract

PURPOSE

The purpose of this study was to evaluate the prognostic value of metabolic tumor volume (MTV) and metabolic index (MI) from fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in patients with nasopharyngeal carcinoma (NPC).

METHODS

From October 2002 to July 2004, 41 patients with NPC who underwent (18)F-FDG PET-CT scan before and after radiotherapy were reviewed retrospectively. All patients received intensity-modulated radiotherapy using 6MV X-rays. We examined the association of MTV and the results of long-term follow-up of the patients.

RESULTS

Patients having tumors with an MTV below 30 cm(3) had significantly better 5-year overall survival (OS) (84.6:46.7%, P = 0.006) and disease-free survival (DFS) (73.1:40.0%, P = 0.014) than patients with an MTV of 30 cm(3) or greater. And the patients with MI below 130 had significantly higher 5-year OS (88.0:43.8%, P = 0.002) and DFS (76.0:37.5%, P = 0.005) than other patients. In the Cox multivariate analysis, MI and metabolic response (MR) were predictive of DFS, and we did not find a significant relationship between standard uptake value (SUV) and OS or DFS.

CONCLUSIONS

The present study shows that tumor volume parameters, especially the combination of MTV and SUV in the "metabolic index", are valuable for predicting long-term survival. High MI may be useful for identifying patients requiring more aggressive treatment.

摘要

目的

本研究旨在评估氟-18-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(18F-FDG PET/CT)中代谢肿瘤体积(MTV)和代谢指数(MI)对鼻咽癌(NPC)患者的预后价值。

方法

回顾性分析 2002 年 10 月至 2004 年 7 月间 41 例 NPC 患者放疗前后 18F-FDG PET/CT 扫描资料。所有患者均接受 6MV X 射线强度调制放疗。我们研究了 MTV 与患者长期随访结果的相关性。

结果

肿瘤 MTV 低于 30 cm3 的患者 5 年总生存率(OS)(84.6:46.7%,P = 0.006)和无病生存率(DFS)(73.1:40.0%,P = 0.014)显著高于 MTV 为 30 cm3 或更大的患者。MI 低于 130 的患者 5 年 OS(88.0:43.8%,P = 0.002)和 DFS(76.0:37.5%,P = 0.005)显著高于其他患者。在 Cox 多因素分析中,MI 和代谢反应(MR)是 DFS 的预测因素,我们未发现 SUV 与 OS 或 DFS 之间存在显著关系。

结论

本研究表明,肿瘤体积参数,尤其是 MTV 和“代谢指数”中的 SUV 的结合,对预测长期生存具有重要价值。高 MI 可能有助于识别需要更积极治疗的患者。

相似文献

1
Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.18F-FDG PET-CT 代谢指标对鼻咽癌的预后价值。
J Cancer Res Clin Oncol. 2010 Jun;136(6):883-9. doi: 10.1007/s00432-009-0729-7. Epub 2009 Nov 20.
2
Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy.同期化疗和调强放疗治疗鼻咽癌患者肿瘤体积的预后价值。
J Cancer Res Clin Oncol. 2014 Jan;140(1):69-76. doi: 10.1007/s00432-013-1542-x. Epub 2013 Oct 31.
3
Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.18F-FDG-PET/CT在鼻咽癌患者中的预后价值:一项系统评价和荟萃分析
Oncotarget. 2017 May 16;8(20):33884-33896. doi: 10.18632/oncotarget.13934.
4
Neural Network-based Automated Classification of 18 F-FDG PET/CT Lesions and Prognosis Prediction in Nasopharyngeal Carcinoma Without Distant Metastasis.基于神经网络的18F-FDG PET/CT对无远处转移鼻咽癌病变的自动分类及预后预测
Clin Nucl Med. 2025 Aug 1;50(8):721-730. doi: 10.1097/RLU.0000000000005942. Epub 2025 May 9.
5
Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.正电子发射断层扫描适配疗法用于霍奇金淋巴瘤患者的一线治疗
Cochrane Database Syst Rev. 2015 Jan 9;1(1):CD010533. doi: 10.1002/14651858.CD010533.pub2.
6
Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.18F-FDG PET/CT、MRI和SPECT在诊断局部残留/复发性鼻咽癌中的比较:一项荟萃分析。
Oral Oncol. 2016 Jan;52:11-7. doi: 10.1016/j.oraloncology.2015.10.010. Epub 2015 Nov 4.
7
Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.放疗或放化疗治疗的头颈癌患者中肿瘤控制及可见坏死情况的影响
J Cancer Res Clin Oncol. 2005 Nov;131(11):758-64. doi: 10.1007/s00432-005-0018-z. Epub 2005 Nov 1.
8
FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描代谢肿瘤体积和总病灶糖酵解预测晚期肺腺癌患者的预后。
J Cancer Res Clin Oncol. 2014 Jan;140(1):89-98. doi: 10.1007/s00432-013-1545-7. Epub 2013 Nov 6.
9
Tumor Asphericity in FDG PET Is an Independent Prognostic Parameter Improving Risk Stratification in Patients with Head and Neck Squamous Cell Carcinoma.FDG PET 中的肿瘤非球形度是改善头颈部鳞状细胞癌患者风险分层的独立预后参数。
J Nucl Med. 2025 May 1;66(5):686-691. doi: 10.2967/jnumed.124.268972.
10
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival?前瞻性评估 18F-氟代脱氧葡萄糖正电子发射断层扫描-计算机断层扫描在复发性宫颈癌中的疗效评估:代谢反应是否可预测生存?
Int J Gynecol Cancer. 2014 Feb;24(2):312-20. doi: 10.1097/IGC.0000000000000038.

引用本文的文献

1
Predictive value of metabolic parameters and apparent diffusion coefficient derived from 18F-FDG PET/MR in patients with non-small cell lung cancer.18F-FDG PET/MR 代谢参数和表观扩散系数对非小细胞肺癌患者的预测价值。
BMC Med Imaging. 2024 Oct 29;24(1):290. doi: 10.1186/s12880-024-01445-8.
2
PET/CT standardized uptake value and EGFR expression predicts treatment failure in nasopharyngeal carcinoma.正电子发射断层扫描/计算机断层扫描标准摄取值和表皮生长因子受体表达预测鼻咽癌治疗失败。
Radiat Oncol. 2023 Feb 22;18(1):33. doi: 10.1186/s13014-023-02231-6.
3
Focal Nasopharyngeal Activity Detected on [F]FDG PET/CT: Clinical Implications and Comparison of Metabolic Parameters for Prediction of Malignancy.

本文引用的文献

1
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.代谢肿瘤体积可预测头颈癌的复发和死亡。
Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1335-41. doi: 10.1016/j.ijrobp.2008.10.060. Epub 2009 Mar 14.
2
The prognostic value of 18F-fluorodeoxyglucose uptake by using serial positron emission tomography and computed tomography in patients with stage III nonsmall cell lung cancer.18F-氟脱氧葡萄糖摄取通过连续正电子发射断层扫描和计算机断层扫描对Ⅲ期非小细胞肺癌患者的预后价值
Am J Clin Oncol. 2008 Oct;31(5):470-5. doi: 10.1097/COC.0b013e31816fc943.
3
Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus.
[F]FDG PET/CT检测到的局限性鼻咽部活性:临床意义及预测恶性肿瘤的代谢参数比较
Nucl Med Mol Imaging. 2022 Dec;56(6):299-305. doi: 10.1007/s13139-022-00771-5. Epub 2022 Sep 10.
4
M1 stage subdivisions based on F-FDG PET-CT parameters to identify locoregional radiotherapy for metastatic nasopharyngeal carcinoma.基于F-FDG PET-CT参数的M1期细分,以确定转移性鼻咽癌的局部区域放射治疗。
Ther Adv Med Oncol. 2022 Aug 12;14:17588359221118785. doi: 10.1177/17588359221118785. eCollection 2022.
5
Pretreatment [F]FDG PET/CT and MRI in the prognosis of nasopharyngeal carcinoma.治疗前[F]氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描及磁共振成像在鼻咽癌预后中的应用
Ann Nucl Med. 2022 Oct;36(10):876-886. doi: 10.1007/s12149-022-01770-4. Epub 2022 Jul 14.
6
Combing MRI Perfusion and F-FDG PET/CT Metabolic Biomarkers Helps Predict Survival in Advanced Nasopharyngeal Carcinoma: A Prospective Multimodal Imaging Study.联合MRI灌注与F-FDG PET/CT代谢生物标志物有助于预测晚期鼻咽癌的生存率:一项前瞻性多模态成像研究
Cancers (Basel). 2021 Mar 28;13(7):1550. doi: 10.3390/cancers13071550.
7
Multiparametric positron emission tomography/magnetic resonance imaging in nasopharyngeal carcinoma: Correlations between magnetic resonance imaging functional parameters and F-fluorodeoxyglucose positron emission tomography imaging biomarkers and their predictive value for treatment failure.多参数正电子发射断层扫描/磁共振成像在鼻咽癌中的应用:磁共振成像功能参数与氟脱氧葡萄糖正电子发射断层扫描成像生物标志物之间的相关性及其对治疗失败的预测价值
Tzu Chi Med J. 2020 Apr 10;33(1):61-69. doi: 10.4103/tcmj.tcmj_4_20. eCollection 2021 Jan-Mar.
8
Quantitative volumetric metabolic measurement of solitary pulmonary nodules by F-18 fluorodeoxyglucose positron emission tomography-computed tomography.通过F-18氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描对孤立性肺结节进行定量体积代谢测量。
Turk Gogus Kalp Damar Cerrahisi Derg. 2019 Oct 23;27(4):557-564. doi: 10.5606/tgkdc.dergisi.2019.17582. eCollection 2019 Oct.
9
Correlation of PET-CT, MRI and histopathology findings in the follow-up of patients with nasopharyngeal cancer.鼻咽癌患者随访中 PET-CT、MRI 与组织病理学检查结果的相关性。
Braz J Otorhinolaryngol. 2021 Nov-Dec;87(6):643-648. doi: 10.1016/j.bjorl.2019.12.004. Epub 2020 Jan 13.
10
Textural features on 18F-FDG PET/CT and dynamic contrast-enhanced MR imaging for predicting treatment response and survival of patients with hypopharyngeal carcinoma.18F-FDG PET/CT及动态对比增强磁共振成像的纹理特征对下咽癌患者治疗反应及生存的预测作用
Medicine (Baltimore). 2019 Aug;98(33):e16608. doi: 10.1097/MD.0000000000016608.
PET/CT测定的代谢肿瘤宽度参数可预测食管鳞状细胞癌的无病生存期和治疗反应。
Mol Imaging Biol. 2009 Jan-Feb;11(1):54-60. doi: 10.1007/s11307-008-0169-9. Epub 2008 Sep 4.
4
Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value.M0期鼻咽癌患者远处转移失败的预测:标准化摄取值的作用
Oral Oncol. 2009 Jan;45(1):52-8. doi: 10.1016/j.oraloncology.2008.03.010. Epub 2008 May 19.
5
Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas.利用2-[(18)F]氟-2-脱氧-D-葡萄糖正电子发射断层显像的标准化摄取值预测鼻咽癌的预后
Radiother Oncol. 2008 May;87(2):211-6. doi: 10.1016/j.radonc.2008.01.009. Epub 2008 Jan 30.
6
Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer.治疗后FDG-PET/CT对肛管癌肿瘤反应及生存情况的预测
Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):180-6. doi: 10.1016/j.ijrobp.2007.09.005. Epub 2007 Nov 8.
7
Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.18F-FDG早期PET用于预测弥漫性大B细胞淋巴瘤患者的预后:基于SUV的评估与视觉分析
J Nucl Med. 2007 Oct;48(10):1626-32. doi: 10.2967/jnumed.107.042093. Epub 2007 Sep 14.
8
Metabolic tumor burden predicts for disease progression and death in lung cancer.代谢肿瘤负荷可预测肺癌的疾病进展和死亡。
Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):328-33. doi: 10.1016/j.ijrobp.2007.04.036.
9
Ensuring the right PET scan for the right patient.为合适的患者确保合适的正电子发射断层扫描(PET)检查。
Lung Cancer. 2008 Jan;59(1):48-56. doi: 10.1016/j.lungcan.2007.07.026. Epub 2007 Sep 12.
10
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.正电子发射断层扫描(PET)评估食管胃交界腺癌的早期代谢反应并指导治疗:MUNICON II期试验
Lancet Oncol. 2007 Sep;8(9):797-805. doi: 10.1016/S1470-2045(07)70244-9.